Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
EQOPEP
1 other identifier
interventional
60
1 country
1
Brief Summary
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 17, 2024
CompletedFirst Submitted
Initial submission to the registry
February 6, 2025
CompletedFirst Posted
Study publicly available on registry
February 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedJanuary 23, 2026
January 1, 2026
1.5 years
February 6, 2025
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of patient quality of life before and after OPEP installation
quality of life is determined by qustionnaire
18 months
Interventions
Quality of life questionnaire for children aged 8 to 13
Quality of life questionnaire for parents of children aged 8 to 13
Quality of life questionnaire for adolescents aged 14 to 17
Quality of life questionnaire for adults
A satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP
Eligibility Criteria
You may qualify if:
- Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.
- The study population will be clinically stable and will be seen in follow-up consultations.
You may not qualify if:
- Children under 8 years of age.
- Patients who use an OPEP
- Patients in the acute exacerbation phase of their DDB
- Patients who are not under regular consultation
- Patients with severe, uncontrolled co-morbidities
- Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol
- Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital Armand Trousseaucollaborator
- Centre Hospitalier Universitaire, Amienslead
Study Sites (1)
CHU Amiens-Picardie
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2025
First Posted
February 11, 2025
Study Start
October 17, 2024
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share